Hefei Lifeon Pharmaceutical Co., Ltd.

SZSE:003020.SZ

25.2 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Revenue 428.847333.618370.753256.711455.974811.817685.153664.961600.609628.617608.357591.089524.715549.094518.091484.161439.526452.514447.89418.3391.921391.921
Cost of Revenue 123.063103.397111.06793.676206.526515.197452.626415.906364.042382.488371.724355.145305.956333.261345.796307.673287.112320.073307.641280.212272.477272.477
Gross Profit 305.784230.221259.685163.035249.448296.62232.526249.055236.568246.129236.633235.944218.76215.833172.295176.488152.413132.441140.25138.088119.444119.444
Gross Profit Ratio 0.7130.690.70.6350.5470.3650.3390.3750.3940.3920.3890.3990.4170.3930.3330.3650.3470.2930.3130.330.3050.305
Reseach & Development Expenses 11.95623.54723.92517.13430.2612.53921.41421.20817.98213.19922.96113.80516.68712.4059.5914.914.4494.3720.0016.5115.4665.466
General & Administrative Expenses -5.28418.046-24.65536.764-5.36615.164-23.9833.9-5.98711.666-21.1725.85-3.1859.5298.251-9.507-2.7326.174-14.6487.7667.7597.759
Selling & Marketing Expenses 212.132158.409171.75594.887148.444183.366148.654158.218146.991162.524154.162162.014145.962143.103108.86112.95386.09385.90483.2993.96673.10173.101
SG&A 234.082176.455182.236131.651143.078198.53124.673192.117141.003174.19132.992187.864142.777152.632117.111103.44683.36192.07968.642101.73283.55583.555
Other Expenses -7.483-0.007-3.701-0.053-0.4814.81846.168-17.90317.7371.669-0.279-0.0442.714-0.01-0.04-1.3380.063-0.4921.4561.27300
Operating Expenses 253.521203.193209.862128.389197.806215.888192.255195.422176.723189.059189.841190.463176.305167.977133.386138.169109.95696.517113.88310789.70589.705
Operating Income 52.26329.01549.82344.31169.09677.92445.33982.67157.12854.91751.31648.2545.09247.79641.19138.57343.14734.52828.09630.71928.18428.184
Operating Income Ratio 0.1220.0870.1340.1730.1520.0960.0660.1240.0950.0870.0840.0820.0860.0870.080.080.0980.0760.0630.0730.0720.072
Total Other Income Expenses Net 7.6121.9815.627-0.053-0.4810.11-0.126-0.0590.039-0.086-0.2792.7265.351-0.072.2420.2240.753-1.8883.1860.9051.8551.855
Income Before Tax 59.87529.00865.45144.25868.61578.03445.21382.61257.16754.83151.03848.20647.80647.78641.15138.54343.2134.03629.55231.99330.0430.04
Income Before Tax Ratio 0.140.0870.1770.1720.150.0960.0660.1240.0950.0870.0840.0820.0910.0870.0790.080.0980.0750.0660.0760.0770.077
Income Tax Expense 9.3981.5535.4572.5573.62711.8936.15510.2336.1247.7044.1536.4485.9136.0955.6974.9276.251.3435.894.6254.625
Net Income 47.05930.37255.29840.24664.98866.14239.05872.3851.04347.12746.88541.75841.89341.69135.45433.61637.01129.03628.20926.10325.41525.415
Net Income Ratio 0.110.0910.1490.1570.1430.0810.0570.1090.0850.0750.0770.0710.080.0760.0680.0690.0840.0640.0630.0620.0650.065
EPS 0.250.190.350.260.410.420.250.60.420.380.510.450.450.270.380.290.540.250.410.220.220.22
EPS Diluted 0.250.190.350.260.410.420.250.60.420.380.510.450.450.270.380.290.540.250.410.220.220.22
EBITDA 71.52531.12763.39942.96573.29682.14245.75285.03658.9457.58952.84148.82547.26350.22944.42343.2843.3736.20232.37336.6931.88131.881
EBITDA Ratio 0.1670.0930.1710.1670.1610.1010.0670.1280.0980.0920.0870.0830.090.0910.0860.0890.0990.080.0720.0880.0810.081